BioMerieux Germany
Presence
BioMerieux Germany is owned by Institut Merieux.
Institut Merieux has a direct presence in 3 countries.
Institut Merieux has 7 subsidiaries including Advanced BioScience Laboratories, BioMerieux and BioMerieux Americas.
They are in:
- Healthcare38%
- Pharmaceuticals38%
- Other25%
Executives
View the org chart displaying its 1 main executives
Most searched biographies at BioMerieux Germany
Create your alert
to follow the executive moves at BioMerieux Germany.
Pharmaceuticals
Institut Merieux has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by BioMerieux Germany
- First-Quarter 2024 Business Review
- bioMérieux presents its new 5-year strategic plan and its targets for profitable growth
- Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel
- bioMérieux – 2023 Financial Results
- Adding value to patient care and outcomes in hospitals
- bioMérieux and the University of Pittsburgh Form Research Partnership
- bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D
- bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
- CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies
- bioMérieux celebrates the First Graduating Class of its Academy of microbiology in Latin America
- View more press releases Close
Social media about BioMerieux Germany
- BioMerieux Germany on Wikipedia, Google News & Yahoo Finance
- BioMerieux Germany on LinkedIn, Twitter & YouTube
